69,90 €
Dosing pen Royal Peptides – SLU-PP-332 5mg/2ml
Modern and practical dosing pen designed for precise and convenient administration of research compounds. Its elegant design, compact construction, and simple operation enable efficient use in laboratory environments. SLU-PP-332 is a breakthrough research compound that acts as a highly potent pan-agonist of estrogen-related receptors (ERRα, ERRβ, and ERRγ). In the field of biomedical research, it represents a new class of substances known as “exercise mimetics.” It is the subject of intense scientific interest due to its potential to drastically increase fatty acid oxidation, stimulate mitochondrial biogenesis, and maximize the endurance capacity of skeletal muscle cells. The pen is supplied in a practical travel case together with a cooling gel pack, with this case included in the product price. Needles are not included in the package and are not available in our product range. The product is intended exclusively for scientific and research purposes.
0 in stock
SLU-PP-332 – dosing pen 5mg/2ml (Next-Generation Exercise Mimetic / ERR Pan-Agonist)
SLU-PP-332 is a highly advanced, non-peptide experimental compound with a small molecular weight, representing the absolute peak of research in metabolic engineering and longevity. This molecule was developed at Washington University as a selective and extremely potent pan-agonist of nuclear ERR receptors (specifically ERRα, ERRβ, and ERRγ subtypes). These receptors act as key switches that cells activate during intense endurance exercise or fasting. In biomedical models, SLU-PP-332 can artificially activate these pathways, causing skeletal muscle cells to immediately exhibit biochemical changes identical to those occurring after running a marathon.
The dosing pen contains 5 mg of highly pure active substance in 2 ml of solution, corresponding to an exact concentration of 2.5 mg/ml. Calculated for precise dosing within research protocols:
1 ml = 100 units (UI) = 100 clicks
0.5 ml (one full rotation of the mechanism) = 50 clicks
Examples of dosing for research purposes:
1 click = 0.025 mg (25 mcg) active substance
4 clicks = 0.100 mg (100 mcg) active substance
10 clicks (0.1 ml) = 0.250 mg (250 mcg) active substance
20 clicks (0.2 ml) = 0.500 mg (500 mcg) active substance
40 clicks (0.4 ml) = 1.000 mg (1000 mcg) active substance
50 clicks (0.5 ml / full rotation) = 1.250 mg (1250 mcg) active substance
This mechanical system ensures absolute precision, repeatability, and flexibility when setting microdoses according to laboratory protocol requirements, without risk of contamination or the need for complex manual dilution.
Effects studied in research
The main focus of SLU-PP-332 research is the activation of gene programs related to oxidative metabolism. Through binding to ERR receptors, a massive up-regulation of the coactivator PGC-1α is observed, triggering mitochondrial biogenesis (formation of new, highly efficient cellular “power plants”). Skeletal muscle cells under the influence of this substance begin to prefer fatty acid (lipid) oxidation over glucose, leading to a significant reduction in adipose tissue.
In in vivo animal studies, SLU-PP-332 has shown remarkable results: test subjects were able to run 70% longer and cover 45% greater distance compared to the control group without prior training. At the same time, the molecule is being studied for its ability to protect against diet-induced obesity and insulin resistance caused by high-fat diets. Research also focuses on its potential therapeutic application in metabolic syndrome, sarcopenia (age-related muscle loss), and cardiac muscle stabilization, where ERR receptors play a critical role in energy metabolism.
Scientific context and sources
As one of the most promising molecules in the field of exercise mimetics, SLU-PP-332 has attracted significant attention in peer-reviewed journals, including The Journal of Pharmacology and Experimental Therapeutics. The latest breakthrough data published in 2023, along with subsequent analyses describing genetic changes in muscle fibers after administration of this compound, are fully available in the PubMed international academic database.
Precise information on molecular stability, systemic effects on glucose metabolism, and prevention of fatty liver degeneration is continuously collected in ClinicalTrials.gov databases and university registries, where this compound serves as a foundational model for the development of future therapies for patients with limited physical mobility.
The Royal Peptides dosing pen provides a modern, safe, and highly sterile solution for handling this advanced experimental molecule in controlled laboratory conditions.
The product is intended exclusively for scientific and research purposes. Not for direct human consumption.
